The table below shows Cocrystal Pharma, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$8.19M
-$16.48M
-$14.67M
-$21.43M
-$12.72M
-$9.83M
Capital expenditure
$12.00K
$8.00K
$118.00K
$74.00K
$52.00K
$240.00K
Investing cash flow
-$12.00K
-$8.00K
-$118.00K
-$74.00K
-$52.00K
-$240.00K
Dividends paid
-
-
-
-
COCP operating cash flow (10-K history)
Cocrystal Pharma, Inc. reported operating cash flow of -$8.19M for fiscal year 2025. That is up 50.3% from -$16.48M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$14.65M (FY 2016) to -$8.19M. Figures come from the company's audited annual reports as filed with the SEC.